Navigation Links
Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
Date:2/25/2008

BALTIMORE, Feb. 25 /PRNewswire/ -- Newly published data by Dr. J. Barthelow Classen shows that vaccines are particularly likely to cause diabetes in children with a strong family history of insulin dependent diabetes. Previous papers provided proof that vaccines cause diabetes in vaccine recipients at a rate which exceeds their benefit in the general population. New data indicates vaccines are particularly toxic to those with a strong family history of diabetes. For example, the hemophilus vaccine which had been proven to cause diabetes in approximately 1 in every 2,000 immunized children in the general public has now been linked to causing diabetes in 1 in every 50 immunized children (2%) who have a sibling with insulin dependent diabetes. The new data is published in the Open Pediatric Medicine Journal. An accompanying article in the same journal links the hepatitis B vaccine to insulin dependent diabetes.

"The recent data shows that common childhood vaccines are especially dangerous to children with a strong family history of diabetes. Parents of a child with a strong family history of insulin dependent diabetes or other should know that the administration of a full series of vaccines may have a greater than 5% chance of causing their child to develop diabetes."

Classen's research has become widely accepted. To view the published papers and to find out the latest information on the effects of vaccines on autoimmune diseases including insulin dependent diabetes visit the Vaccine Safety Web site http://www.vaccines.net/newpage11.htm

Classen Immunotherapies, Inc.

6517 Montrose Avenue Baltimore, MD 21212 U.S.A.

Tel: (410) 377-8526 Classen@vaccines.net

http://vaccines.net


'/>"/>
SOURCE Classen Immunotherapies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016
2. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
3. Discovery of new cause of mental retardation simplifies search for treatments
4. New Drug to Prevent Bone Loss Caused by Breast Cancer Treatment
5. ORNL super water repellent could cause big wave in market
6. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
7. Individual differences caused by shuffled chunks of DNA in the human genome
8. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
9. 3 strikes, youre out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause
10. Novocell Reports Successful Use of Stem Cells to Generate Insulin in Mice
11. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... RESEARCH TRIANGLE PARK, N.C. , April 27, ... ) announced today that Martine Rothblatt , Ph.D., ... provide an overview and update on the company,s business ... Care Conference. The presentation will take place ... Time, and can be accessed via a live webcast ...
(Date:4/27/2016)... , ... April 27, 2016 , ... ... Jon Clark has joined the company as an Expert Consultant. Mr. Clark ... industry collaborations and managing the development of small molecule monographs based on analytical ...
(Date:4/27/2016)... (PRWEB) , ... April 27, 2016 , ... ... for simultaneous preclinical PET (Positron Emission Tomography) and MRI (Magnetic Resonance Imaging) in ... understanding disease and testing novel treatments in small animal subjects. Simultaneous PET/MRI imaging ...
(Date:4/27/2016)... MIAMI (PRWEB) , ... April 27, 2016 , ... ... a mutual endorsement of an Asia-Pacific Symposium as other research and development initiatives for ... of Santiago officials and top Global Stem Cells Group executives began meeting to establish ...
Breaking Biology Technology:
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):